Auzon Steffy

1.5k total citations
5 papers, 70 citations indexed

About

Auzon Steffy is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Auzon Steffy has authored 5 papers receiving a total of 70 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Cancer Research. Recurrent topics in Auzon Steffy's work include Cancer Genomics and Diagnostics (2 papers), Ubiquitin and proteasome pathways (2 papers) and Neuroblastoma Research and Treatments (1 paper). Auzon Steffy is often cited by papers focused on Cancer Genomics and Diagnostics (2 papers), Ubiquitin and proteasome pathways (2 papers) and Neuroblastoma Research and Treatments (1 paper). Auzon Steffy collaborates with scholars based in United States and Switzerland. Auzon Steffy's co-authors include Jennifer L. Harris, Shailaja Kasibhatla, Celin Tompkins, Shifeng Pan, Mindy H. Hsieh, Wenqi Gao, H. Martin Seidel, Chun Li, Nicholas Ng and Fangxian Sun and has published in prestigious journals such as Cancer Research, Molecular Cancer Therapeutics and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Auzon Steffy

5 papers receiving 70 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Auzon Steffy United States	3	43	22	16	13	7	5	70
Celin Tompkins United States	3	43 1.0×	22 1.0×	14 0.9×	17 1.3×	7 1.0×	3	65
SeongShick Ryu South Korea	4	47 1.1×	22 1.0×	10 0.6×	6 0.5×	6 0.9×	10	57
Sudeep Prajapati Italy	4	36 0.8×	11 0.5×	17 1.1×	12 0.9×	3 0.4×	7	60
A. V. Artamonov Russia	6	42 1.0×	13 0.6×	9 0.6×	15 1.2×	13 1.9×	18	79
Takushi Togashi Japan	5	38 0.9×	15 0.7×	6 0.4×	11 0.8×	5 0.7×	8	61
Fang-Yu Tsai Taiwan	3	71 1.7×	17 0.8×	5 0.3×	18 1.4×	5 0.7×	4	101
Lenora A. Pluchino United States	4	35 0.8×	22 1.0×	5 0.3×	6 0.5×	2 0.3×	4	70
Alexandra Ambrico United States	2	80 1.9×	13 0.6×	3 0.2×	12 0.9×	6 0.9×	2	100
Nadine V. Conchinha Portugal	2	51 1.2×	6 0.3×	8 0.5×	6 0.5×	3 0.4×	2	75
Eric Bernstein United States	5	24 0.6×	30 1.4×	5 0.3×	36 2.8×	3 0.4×	8	82

Countries citing papers authored by Auzon Steffy

Since Specialization

Citations

This map shows the geographic impact of Auzon Steffy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Auzon Steffy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Auzon Steffy more than expected).

Fields of papers citing papers by Auzon Steffy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Auzon Steffy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Auzon Steffy. The network helps show where Auzon Steffy may publish in the future.

Co-authorship network of co-authors of Auzon Steffy

This figure shows the co-authorship network connecting the top 25 collaborators of Auzon Steffy. A scholar is included among the top collaborators of Auzon Steffy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Auzon Steffy. Auzon Steffy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Liao, Debbie, Ryan J. Hansen, Auzon Steffy, et al.. (2024). Abstract 3631: Preclinical and clinical pharmacodynamic characterization of BBI-355, a novel, orally bioavailable, and selective CHK1 inhibitor being evaluated in the first-in-human Phase 1/2 POTENTIATE clinical trial of patients with cancer harboring oncogene amplifications. Cancer Research. 84(6_Supplement). 3631–3631. 1 indexed citations

2.

Hansen, Ryan J., Auzon Steffy, AnneMarie Culazzo Pferdekamper, et al.. (2024). Abstract 613: Oral CHK1 inhibitor BBI-355 allows flexibility of dose and schedule with demonstration of monotherapy and combinational antitumor activity in extrachromosomal DNA (ecDNA) driven preclinical models. Cancer Research. 84(6_Supplement). 613–613. 1 indexed citations

3.

Dai, Cheng, Jun Liu, Dong Han, et al.. (2016). Discovery of Pyridinyl Acetamide Derivatives as Potent, Selective, and Orally Bioavailable Porcupine Inhibitors. ACS Medicinal Chemistry Letters. 7(7). 676–680. 44 indexed citations

4.

Michellys, Pierre‐Yves, Bei Chen, Tao Jiang, et al.. (2015). Design and synthesis of novel selective anaplastic lymphoma kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(3). 1090–1096. 11 indexed citations

5.

Li, Nanxin, Pierre‐Yves Michellys, Sung Joon Kim, et al.. (2011). Abstract B232: Activity of a potent and selective phase I ALK inhibitor LDK378 in naive and crizotinib-resistant preclinical tumor models.. Molecular Cancer Therapeutics. 10(11_Supplement). B232–B232. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact